Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes

  • Guardiola, Montse
  • Rehues, Pere
  • Amigó, Núria|||0000-0002-0116-9145
  • Arrieta, Francisco|||0000-0001-7571-0451
  • Botana, Manuel|||0000-0002-3825-6111
  • Gimeno Orna, José Antonio|||0000-0002-9901-4992
  • Girona, Josefa
  • Martínez Montoro, José Ignacio
  • Ortega, Emilio|||0000-0002-2217-8905
  • Pérez, Antonio|||0000-0001-5528-1143
  • Sánchez Margalet, Víctor|||0000-0001-8638-8680
  • Pedro Botet Montoya, Juan|||0000-0001-7366-6821
  • Ribalta, Josep|||0000-0002-8879-4719
  • Aguilar, Manuel|||0000-0001-9657-5949
  • Becerra Fernández, Antonio
  • Botana, Manuel|||0000-0002-3825-6111
  • Campos Pastor, María del Mar
  • Durán García, Santiago
  • Fornos Pérez, José Antonio
  • Maldonado Castro, Gonzalo Fernando
  • Manrique Mutiozábal, Carmela Teresa
  • Mañas Martínez, Ana Belén
  • Mera Gallego, Inés
  • Montánez Fernández, Laura
  • Navarro Pérez, Jorge|||0000-0001-7414-7126
  • Obaya Rebollar, Juan Carlos|||0000-0002-2879-1743
  • Ortega, Emilio|||0000-0002-2217-8905
  • Ortiz Zúñiga, Ángel Michael|||0000-0002-2982-5896
  • Pardo Franco, José Luis
  • Pedro Botet Montoya, Juan|||0000-0001-7366-6821
  • Pérez Sánchez, José Carlos
  • Puig Jové, Carlos|||0000-0001-9466-2627
  • Ribalta, Josep|||0000-0002-8879-4719
  • Tébar Massó, Francisco Javier
  • Zubiría Gortázar, Juan Manuel
The burden of cardiovascular disease is particularly high among individuals with diabetes, even when LDL cholesterol is normal or within the therapeutic target. Despite this, cholesterol accumulates in their arteries, in part, due to persistent atherogenic dyslipidaemia characterized by elevated triglycerides, remnant cholesterol, smaller LDL particles and reduced HDL cholesterol. The causal link between dyslipidaemia and atherosclerosis in T2DM is complex, and our contention is that a deeper understanding of lipoprotein composition and functionality, the vehicle that delivers cholesterol to the artery, will provide insight for improving our understanding of the hidden cardiovascular risk of diabetes. This narrative review covers three levels of complexity in lipoprotein characterization: 1-the information provided by routine clinical biochemistry, 2-advanced nuclear magnetic resonance (NMR)-based lipoprotein profiling and 3-the identification of minor components or physical properties of lipoproteins that can help explain arterial accumulation in individuals with normal LDLc levels, which is typically the case in individuals with T2DM. This document highlights the importance of incorporating these three layers of lipoprotein-related information into population-based studies on ASCVD in T2DM. Such an attempt should inevitably run in parallel with biotechnological solutions that allow large-scale determination of these sets of methodologically diverse parameters.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparative mortality of dominant Staphylococcus aureus lineages in human bacteremia and animal infection models

  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Bravo Bravo, Marc|||0000-0002-3173-2242
  • Cañas, María Alexandra|||0000-0002-0521-7204
  • Gómez, Andromeda-Celeste|||0000-0002-0075-6903
  • Gómez-Sánchez, Inmaculada|||0000-0002-4255-0882
  • Miró, José M.|||0000-0001-8057-7755
  • Gibert, Isidre|||0000-0003-1442-2258
  • Gasch, Oriol|||0000-0001-8518-458X
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Yero, Daniel|||0000-0002-6234-4082
  • Pich, Oscar Q.|||0000-0003-3561-630X
Staphylococcus aureus is a major human pathogen responsible for severe infections, including infective endocarditis. While host factors influencing disease outcome are well characterized, lineage-specific virulence mechanisms remain poorly defined. Herein, we investigated eighty-nine bacteremic S. aureus isolates from nine globally distributed lineages using Galleria mellonella and rabbit infection models, alongside phenotypic and transcriptomic analyses. Despite marked genotypic and phenotypic heterogeneity, mortality in G. mellonella varied significantly between lineages and correlated with hemolytic activity. ST398 isolates demonstrated heightened larval virulence linked to increased α- and δ-hemolysin production, whereas CC30 strains exhibited reduced growth, biofilm formation and infectivity. The ST398 agrC mutant Sau7 displayed a distinct phenotype, with elevated biofilm production but attenuated larval virulence. However, in the rabbit endocarditis model, Sau7 exhibited mortality rates similar to other ST398 isolates and was associated with larger vegetations and higher bacterial burdens, underscoring the role of the agr system in colonization and biofilm development. Transcriptomic profiling highlighted quorum-sensing pathways and hemolysin expression as key drivers of virulence in ST398 strains. Our findings reveal clear lineage-specific differences in S. aureus pathogenicity and demonstrate that virulence is context dependent, varying across infection models. These results emphasize the importance of using complementary in vivo systems to capture the multifaceted nature of S. aureus disease potential and to better predict infection outcomes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Is ampicillin plus cephalosporins a therapeutic option for Ampicillin-Susceptible Enterococcus faecium?

  • Bierge, Paula|||0000-0003-0917-3445
  • Gómez-Sánchez, Inmaculada|||0000-0002-4255-0882
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Capilla, Silvia|||0000-0002-7274-2973
  • Casabella Pernas, Antonio|||0000-0002-2534-3689
  • Espasa, Mateu|||0000-0003-4822-1024
  • Novais, Carla|||0000-0002-3826-6731
  • Miró, José M.|||0000-0001-8057-7755
  • Pich, Oscar Q.|||0000-0003-3561-630X
  • Gasch, Oriol|||0000-0001-8518-458X
Objectives: Enterococcus faecium, a significant hospital associated pathogen, poses substantial treatment challenges. While combinations of ampicillin with cephalosporins are first-line therapies to treat Enterococcus faecalis high-mortality-rates infections, their efficacy against ampicillin-susceptible E. faecium (ASEfm) is less clear. This study evaluates the effectiveness of combining ampicillin with ceftriaxone or ceftaroline against ASEfm strains. Methods: Ten ASEfm bloodstream isolates from complicated infections were analyzed. Susceptibility to several antibiotics, including ceftriaxone, ceftaroline, and cefotaxime, was determined using standard methods. Time-kill assays were conducted to assess the synergistic and additive effects of ampicillin in combination with ceftriaxone or ceftaroline. Results: Time-kill studies revealed that ampicillin combined with ceftaroline demonstrated synergistic and/or additive effects in 7 out of 10 strains analyzed. In contrast, ampicillin combined with ceftriaxone showed less pronounced synergy, with only 3 out of 10 strains exhibiting synergistic and/or additive effects. Conclusions: Our findings indicate that ampicillin combined with ceftaroline, or ceftriaxone provides synergistic activity against some but not all ASEfm clinical isolates. The observed synergy suggests that these combinations could offer a potential therapeutic option for challenging ASEfm infections.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

mGem, Population genomics of Staphylococcus aureus bacteremia and the impact of the COVID-19 pandemic

  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Buiatte, Ana Beatriz Garcez
  • Wang, Rebecca
  • Gasch, Oriol|||0000-0001-8518-458X
  • Martin, Isabella W.|||0000-0001-7974-9767
  • Andam, Cheryl P.|||0000-0003-4428-0924
  • Pich, Oscar Q.|||0000-0003-3561-630X
The pressure of the coronavirus disease 2019 (COVID-19) pandemic on global healthcare systems and societies was unprecedented in the modern era. Social restrictions, containment measures, and disruptions in antimicrobial prescriptions and consumption during the pandemic have been reported to alter the epidemiology of bacterial diseases, although these effects likely differed markedly between locations. Here, we compare the clinical, clonal distribution, and genomic features of Staphylococcus aureus bloodstream isolates before, during, and after COVID-19 in two hospitals on different continents: Parc Taulí University Hospital (Spain) and Dartmouth-Hitchcock Medical Center (USA). We hypothesize that pandemic-related environmental perturbations, such as those due to infection control practices and antimicrobial exposure, may have contributed to shifts in the diversity of circulating bacterial lineages and genomic elements. Our findings revealed changes in the distribution of low-frequency clones, antimicrobial resistance genes, and virulence factors, potentially reflecting changes in selective pressures in clinical environments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Single point mutations in global regulatory genes restore cephalosporin resistance in a low-MIC Enterococcus faecium natural isolate

  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Bierge, Paula|||0000-0003-0917-3445
  • Gómez-Sánchez, Inmaculada|||0000-0002-4255-0882
  • Guitart-Matas, Judith|||0009-0009-9329-9139
  • Monsálvez, Víctor|||0009-0003-0126-3224
  • Rabanal, Patricia
  • Pereira, Ana P.
  • Freitas, Ana R.|||0000-0002-7326-4133
  • Peixe, Luisa
  • Espasa, Mateu|||0000-0003-4822-1024
  • Gasch, Oriol|||0000-0001-8518-458X
  • Novais, Carla|||0000-0002-3826-6731
  • Pich, Oscar Q.|||0000-0003-3561-630X
Enterococcus faecium exhibits intrinsic resistance to cephalosporins (CPHs), yet the genetic determinants of this phenotype remain incompletely understood. To date, E. faecium strains with low minimum inhibitory concentrations (MICs) of CPH have only been described following genetic manipulation. At Parc Taulí University Hospital, we identified a clinical isolate of ampicillin-susceptible E. faecium (Efm5) that exhibited unusually low MICs to cefotaxime (1 mg/L), ceftriaxone (3 mg/L), and ceftaroline (0.19 mg/L). Upon single exposure to ceftriaxone (100 mg/L), Efm5 rapidly yielded variants with markedly increased MICs of ceftriaxone (>256 mg/L) and cefotaxime (>32 mg/L), while MICs of ampicillin and ceftaroline were unaffected. Whole-genome sequencing revealed that the high-MIC variants carried single-nucleotide polymorphisms leading to non-synonymous mutations in croS, nusG, or rpoB genes. Phenotypic assays confirmed that these mutations were associated with ceftriaxone resistance, and immunoblots revealed increased expression of penicillin-binding protein 5 (PBP5) in all the high-MIC variants. Transcriptional profiling showed upregulation of the pbp5 operon, which includes ftsW, psr, and pbp5, in the croS variants. This study provides evidence that E. faecium isolates with low MICs to CPH can arise in clinical settings without laboratory manipulation, enabling further investigation of resistance pathways.
Repisalud
Publicación Artículo científico (JournalArticle)

Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia

  • González-Rincón, Julia
  • Gómez, Sagrario
  • Martinez, Nerea
  • Troulé, Kevin
  • Perales-Patón, Javier
  • Derdak, Sophia
  • Beltrán, Sergi
  • Fernández-Cuevas, Belén
  • Pérez-Sanz, Nuria
  • Nova-Gurumeta, Sara
  • Gut, Ivo
  • Al-Shahrour, Fatima
  • Piris, Miguel A
  • García-Marco, José A
  • Sánchez-Beato, Margarita
Chronic lymphocytic leukaemia is the most prevalent leukaemia in Western countries. It is an incurable disease characterized by a highly variable clinical course. Chronic lymphocytic leukaemia is an ideal model for studying clonal heterogeneity and dynamics during cancer progression, response to therapy and/or relapse because the disease usually develops over several years. Here we report an analysis by deep sequencing of sequential samples taken at different times from the affected organs of two patients with 12- and 7-year disease courses, respectively. One of the patients followed a linear pattern of clonal evolution, acquiring and selecting new mutations in response to salvage therapy and/or allogeneic transplantation, while the other suffered loss of cellular tumoral clones during progression and histological transformation.
Repisalud
Publicación Artículo científico (JournalArticle)

Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features

  • Manso, Rebeca
  • González-Rincón, Julia
  • Rodríguez-Justo, Manuel
  • Roncador, Giovanna
  • Gómez, Sagrario
  • Sánchez-Beato, Margarita
  • Piris, Miguel A
  • Rodríguez-Pinilla, Socorro M
The overlap of morphology and immunophenotype between angioimmunoblastic T-cell lymphoma (AITL) and other nodal peripheral T-cell lymphomas (n-PTCLs) is a matter of current interest whose clinical relevance and pathogenic background have not been fully established. We studied a series of 98 n-PTCL samples (comprising 57 AITL and 41 PTCL-NOS) with five TFH antibodies (CD10, BCL-6, PD-1, CXCL13, ICOS), looked for mutations in five of the genes most frequently mutated in AITL (TET2, DNMT3A, IDH2, RHOA and PLCG1) using the Next-Generation-Sequencing Ion Torrent platform, and measured the correlations of these characteristics with morphology and clinical features. The percentage of mutations in the RHOA and TET2 genes was similar (23.5% of cases). PLCG1 was mutated in 14.3%, IDH2 in 11.2% and DNMT3A in 7.1% of cases, respectively. In the complete series, mutations in RHOA gene were associated with the presence of mutations in IDH2, TET2 and DNMT3A (p < 0.001, p = 0.043, and p = 0.029, respectively). Fourteen cases featured RHOA mutations without TET2 mutations. A close relationship was found between the presence of these mutations and a TFH-phenotype in AITL and PTCL-NOS patients. Interestingly, BCL-6 expression was the only TFH marker differentially expressed between AITL and PTCL-NOS cases. There were many fewer mutated cases than there were cases with a TFH phenotype. Overall, these data suggest alternative ways by which neoplastic T-cells overexpress these proteins. On the other hand, no clinical or survival differences were found between any of the recognized subgroups of patients with respect to their immunohistochemistry or mutational profile.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies

  • Prieto-Torres, L.
  • Rodriguez-Pinilla, S.M.
  • Onaindia, A.
  • Ara, M.
  • Requena, L.
  • Piris, M.Á.
Primary cutaneous CD30-positive T-cell lymphoproliferative disorders are the second most common subgroup of cutaneous T-cell lymphomas. They include two clinically different entities with some overlapping features and borderline cases: lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. Molecular studies of primary cutaneous anaplastic large cell lymphoma reveal an increasing level of heterogeneity that is associated with histological and immunophenotypic features of the cases and their response to specific therapies. Here, we review the most significant genetic, epigenetic and molecular alterations described to date in primary cutaneous CD30-positive T-cell lymphoproliferative disorders, and their potential as therapeutic targets.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Rapid Phenotype-Driven Gene Sequencing with the NeoSeq Panel: A Diagnostic Tool for Critically Ill Newborns with Suspected Genetic Disease

  • de Castro, M.J.
  • Gonzalez-Vioque, E.
  • Barbosa-Gouveia, S.
  • Salguero, E.
  • Rite, S.
  • Lopez-Suarez, O.
  • Perez-Munuzuri, A.
  • Couce, M.L.
New genomic sequencing techniques have shown considerable promise in the field of neonatology, increasing the diagnostic rate and reducing time to diagnosis. However, several obstacles have hindered the incorporation of this technology into routine clinical practice. We prospectively evaluated the diagnostic rate and diagnostic turnaround time achieved in newborns with suspected genetic diseases using a rapid phenotype-driven gene panel (NeoSeq) containing 1870 genes implicated in congenital malformations and neurological and metabolic disorders of early onset (<2 months of age). Of the 33 newborns recruited, a genomic diagnosis was established for 13 (39.4%) patients (median diagnostic turnaround time, 7.5 days), resulting in clinical management changes in 10 (76.9%) patients. An analysis of 12 previous prospective massive sequencing studies (whole genome (WGS), whole exome (WES), and clinical exome (CES) sequencing) in newborns admitted to neonatal intensive care units (NICUs) with suspected genetic disorders revealed a comparable median diagnostic rate (37.2%), but a higher median diagnostic turnaround time (22.3 days) than that obtained with NeoSeq. Our phenotype-driven gene panel, which is specific for genetic diseases in critically ill newborns is an affordable alternative to WGS and WES that offers comparable diagnostic efficacy, supporting its implementation as a first-tier genetic test in NICUs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Two independent consecutive lymphoma cases carry an identical MYD88 mutation but differ in their IGVH rearrangement

  • Prieto-Torres, L
  • Trascasa, A
  • Manso, R
  • Machan, S
  • Cieza-Diaz, D
  • Olmedilla, G
  • Garcia-Garcia, M
  • Ara-Martin, M
  • Requena, L
  • Piris, MA
  • Rodriguez-Pinilla, SM
Several studies have provided evidence of the presence of lymphoma stem cells by showing the apparent transmission of premalignant lymphoid cells in allogeneic bone marrow transplantation, where the donor and recipient develop the same lymphoid disease.1-6 The lymphoid neoplasms do not develop at the same time, and in some cases, a different immunoglobulin heavy chain (IgH) rearrangement occurs in the two tumours. These data support the theory of a common lymphoma precursor cell (CPC) and make it less likely that it is due to a circulating donor tumour cell. Recently, Hattori et al.7 published genetic evidence of CPC in primary central nervous system diffuse large B-cell lymphoma (PCNS-DLBCL), suggesting that intra- and extra-CNS tumours in the same patient are derived from CPC with myeloid differentiation factor 88 (MYD88) L265P gene mutations, which arise before or after the IgH rearrangement. They suggested that CPC maps to different positions during B-lineage differentiation. The position after IgH rearrangement and even after hypermutation at the variable region could explain the appearance of clonally related lymphomas, whereas the emergence of CPC before IgH rearrangement might account for the presence of clonally unrelated B-cell lymphomas in the same patient because divergence may occur before the Variable-Diversity-Junctional (VDJ) rearrangements.